Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1963 3
1964 7
1966 1
1967 1
1968 3
1969 4
1970 4
1971 5
1972 6
1973 3
1974 4
1975 2
1976 4
1977 5
1978 6
1979 13
1980 11
1981 9
1982 14
1983 19
1984 35
1985 19
1986 28
1987 21
1988 35
1989 20
1990 29
1991 31
1992 35
1993 43
1994 42
1995 31
1996 46
1997 24
1998 17
1999 22
2000 18
2001 14
2002 18
2003 30
2004 31
2005 39
2006 24
2007 22
2008 27
2009 37
2010 29
2011 38
2012 28
2013 29
2014 19
2015 24
2016 25
2017 31
2018 35
2019 36
2020 43
2021 33
Text availability
Article attribute
Article type
Publication date

Search Results

1,183 results
Results by year
Filters applied: . Clear all
Page 1
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab.
Kobayashi T, Ito K, Kojima T, Kato M, Kanda S, Hatakeyama S, Matsui Y, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Kamiyama M, Ogawa O, Kitamura H, Nishiyama H; Japan Urological Oncology Group. Kobayashi T, et al. Among authors: nakanishi s. Cancer Sci. 2021 Feb;112(2):760-773. doi: 10.1111/cas.14762. Epub 2020 Dec 21. Cancer Sci. 2021. PMID: 33283385 Free PMC article.
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells.
Baghdadi M, Wada H, Nakanishi S, Abe H, Han N, Putra WE, Endo D, Watari H, Sakuragi N, Hida Y, Kaga K, Miyagi Y, Yokose T, Takano A, Daigo Y, Seino KI. Baghdadi M, et al. Among authors: nakanishi s. Cancer Res. 2016 Oct 15;76(20):6030-6042. doi: 10.1158/0008-5472.CAN-16-1170. Epub 2016 Aug 22. Cancer Res. 2016. PMID: 27550451 Free article.
Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study.
Fushimi Y, Obata A, Sanada J, Iwamoto Y, Mashiko A, Horiya M, Mizoguchi-Tomita A, Nishioka M, Kan Y, Kinoshita T, Okauchi S, Hirukawa H, Kohara K, Tatsumi F, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Fushimi Y, et al. Among authors: nakanishi s. J Diabetes Res. 2020 Apr 2;2020:4861681. doi: 10.1155/2020/4861681. eCollection 2020. J Diabetes Res. 2020. PMID: 32337293 Free PMC article.
Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study.
Kinoshita T, Shimoda M, Nakashima K, Fushimi Y, Hirata Y, Tanabe A, Tatsumi F, Hirukawa H, Sanada J, Kohara K, Irie S, Kimura T, Nakamura Y, Nishioka M, Obata A, Nakanishi S, Mune T, Kaku K, Kaneto H. Kinoshita T, et al. Among authors: nakanishi s. J Diabetes Investig. 2020 Nov;11(6):1612-1622. doi: 10.1111/jdi.13279. Epub 2020 May 26. J Diabetes Investig. 2020. PMID: 32329963 Free PMC article.
[Secondary hyperparathyroidism].
Nakanishi S, Fukagawa M. Nakanishi S, et al. Nihon Rinsho. 2005 Oct;63 Suppl 10:341-6. Nihon Rinsho. 2005. PMID: 16279659 Review. Japanese. No abstract available.
1,183 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page